365 related articles for article (PubMed ID: 24335570)
1. Immunotherapeutic approaches to treat multiple myeloma.
Roeven MW; Hobo W; Schaap N; Dolstra H
Hum Vaccin Immunother; 2014; 10(4):896-910. PubMed ID: 24335570
[TBL] [Abstract][Full Text] [Related]
2. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
Chung C
Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
[TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis and immunotherapy of multiple myeloma.
Tamura H
Int J Hematol; 2018 Mar; 107(3):278-285. PubMed ID: 29368256
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma.
Podar K; Jager D
Curr Cancer Drug Targets; 2017; 17(9):782-805. PubMed ID: 28201977
[TBL] [Abstract][Full Text] [Related]
5. Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy.
Cho SF; Anderson KC; Tai YT
Front Immunol; 2018; 9():1821. PubMed ID: 30147690
[TBL] [Abstract][Full Text] [Related]
6. Role of Immune Therapies for Myeloma.
Rosenblatt J; Avigan D
J Natl Compr Canc Netw; 2015 Nov; 13(11):1440-7. PubMed ID: 26553769
[TBL] [Abstract][Full Text] [Related]
7. Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.
Guillerey C; Nakamura K; Vuckovic S; Hill GR; Smyth MJ
Cell Mol Life Sci; 2016 Apr; 73(8):1569-89. PubMed ID: 26801219
[TBL] [Abstract][Full Text] [Related]
8. Cellular immunotherapy in multiple myeloma.
Vo MC; Lakshmi TJ; Jung SH; Cho D; Park HS; Chu TH; Lee HJ; Kim HJ; Kim SK; Lee JJ
Korean J Intern Med; 2019 Sep; 34(5):954-965. PubMed ID: 30754964
[TBL] [Abstract][Full Text] [Related]
9. Potential of NK cells in multiple Myeloma therapy.
Khan AM; Devarakonda S; Bumma N; Chaudhry M; Benson DM
Expert Rev Hematol; 2019 Jun; 12(6):425-435. PubMed ID: 31070067
[No Abstract] [Full Text] [Related]
10. Current developments in immunotherapy in the treatment of multiple myeloma.
Köhler M; Greil C; Hudecek M; Lonial S; Raje N; Wäsch R; Engelhardt M
Cancer; 2018 May; 124(10):2075-2085. PubMed ID: 29409124
[TBL] [Abstract][Full Text] [Related]
11. Drug-mediated and cellular immunotherapy in multiple myeloma.
Ritchie DS; Quach H; Fielding K; Neeson P
Immunotherapy; 2010 Mar; 2(2):243-55. PubMed ID: 20635931
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for multiple myeloma.
Rosenblatt J; Bar-Natan M; Munshi NC; Avigan DE
Expert Rev Hematol; 2014 Feb; 7(1):91-6. PubMed ID: 24417573
[TBL] [Abstract][Full Text] [Related]
13. Novel immunotherapies.
Yi Q
Cancer J; 2009; 15(6):502-10. PubMed ID: 20010170
[TBL] [Abstract][Full Text] [Related]
14. [Research Progress of Bispecific Antibodies in Treatment of Multiple Myeloma--Review].
Han F; Zhang XP; Xi YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):952-956. PubMed ID: 38926994
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in multiple myeloma--possibility or probability?
Harrison SJ; Cook G
Br J Haematol; 2005 Aug; 130(3):344-62. PubMed ID: 16042684
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell immunotherapy against multiple myeloma: Progress and possibilities.
Liu P; Jin Y; Sattar H; Liu H; Xie W; Zhou F
J Leukoc Biol; 2018 May; 103(5):821-828. PubMed ID: 29733502
[TBL] [Abstract][Full Text] [Related]
17. Cellular immunotherapy for multiple myeloma.
Rosenblatt J; Avigan D
Best Pract Res Clin Haematol; 2008 Sep; 21(3):559-77. PubMed ID: 18790455
[TBL] [Abstract][Full Text] [Related]
18. Immunologic approaches for the treatment of multiple myeloma.
Rasche L; Weinhold N; Morgan GJ; van Rhee F; Davies FE
Cancer Treat Rev; 2017 Apr; 55():190-199. PubMed ID: 28431262
[TBL] [Abstract][Full Text] [Related]
19. Adoptive cell therapy in multiple Myeloma.
Vallet S; Pecherstorfer M; Podar K
Expert Opin Biol Ther; 2017 Dec; 17(12):1511-1522. PubMed ID: 28857616
[TBL] [Abstract][Full Text] [Related]
20. Is immunotherapy here to stay in multiple myeloma?
Rodríguez-Otero P; Paiva B; Engelhardt M; Prósper F; San Miguel JF
Haematologica; 2017 Mar; 102(3):423-432. PubMed ID: 28082344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
